𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Noninvasive measurement of femoral blood flow and portal pressure response to propranolol in patients with cirrhosis

✍ Scribed by Angelo Luca; Juan Carlos Garí-Pagán; Faust Feu; Juan Carlos Lopez-Talavera; Mercedes Fernández; Concepció Bru; Jaime Bosch; Juan Rodés


Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
721 KB
Volume
21
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis


This study investigated the correlation between changes in hepatic and systemic hemodynamics and femoral blood flow (FBF), measured by dual-beam pulsed wave Doppler, in 58 portal hypertensive patients receiving propranolol(O.15 mg/Kg intravenously; n = 44) or placebo (n = 14) under double-blind conditions. Placebo administration had no effects. Propranolol caused significant reductions (P < .0001) in hepatic venous pressure gradient (HVPG from 19.1 I 4.1 to 16.2 5 4.2 mm Hg), azygos blood flow (from 563 5 204 to 387 I 176 mJJ min), cardiac index (CI; from 4.4 5 1.0 to 3.3 5 0.8 Urn2/ min), and FBF (from 237 5 79 to 176 5 58 mIJm'/min). In 17 patients HVPG decreased below 12 mm Hg and/or more than 20% of the baseline value (good response; mean change, -26 I 8%); in the remaining 27 patients (poor response) the mean change in HVPG was less: -9 t 6%. Patients with a good response had bled less often from varices, had significantly higher FBF (272 73 vs. 215 5 76 mLlm2/min) and lower baseline HVPG (16.8 t 3.9 vs. 20.6 2 3.6 mm Hg) than those with poor response in HVPG. The good response was also associated with greater decreases in FBF (-33 ? 12 vs. -19 i-13% in poor responders), CI (-30 5 9 vs. -19 I 12%), and heart rate (-19 5 5 vs. -16 2 6%). A decrease in FBF of >2W0 predicted a good response in 16 of 28 patients (positive predictive value, 57%). A negative test (decrease in femoral blood flow of <20%) predicted a lack of response in HVPG in 15 of 16 patients (negative predictive value, 94%). This study suggests that the noninvasive measurements of FBF allow the identification of patients with a poor response of HVPG to propranolol. However, measurements of HVPG would still be needed for patients Abbreviations: HVPG, hepatic venous pressure gradient; CI, cardiac index; M, mean; SD, standard deviation; FHVP, free hepatic venous pressure; WHVP, wedged hepatic venous pressure; IV, intravenous.


📜 SIMILAR VOLUMES


Reduction of variceal pressure by propra
✍ Faust Feu; Josep María Bordas; Angelo Luca; Joan Carles García-Pagán; Angels Esc 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 848 KB

This study investigated the correlation between changes in hepatic hemodynamics and esophageal variceal pressuremeasured with a noninvasive, pressure-sensitive endoscopic gaugein 37 portal-hypertensive cirrhotic patients receiving propranolol (0.15 mg/kg, intravenously; n = 21) or placebo (n = 16) u

Daily variation in portal blood flow and
✍ D Alvarez; M de las Heras; R Abecasis; R Terg; S Gerona; L Albornoz; O Galdame; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB 👁 2 views

A nocturnal increase in portal pressure and blood flow was demonstrated in patients with cirrhosis, suggesting Patients. Fourteen patients with cirrhosis (10 men and 4 women, that these hemodynamic changes may contribute to the mean age 53 { 6 years [mean { SEM]; range, 35-63 years) were triggering

The effects of ethanol administration on
✍ Joanna B. Ready; Kenneth F. Hossack; William G. Rector Jr. 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 394 KB 👁 2 views

The pathogenesis of variceal hemorrhage is not well understood. Portal pressure and gastroesophageal collateral (azygous) blood flow are similar in patients with cirrhosis with or without a history of variceal bleeding. However, acute increases in these parameters in individual patients might predis

Enhancement of portal pressure reduction
✍ Joan Carles Garcia-Pagan; Miquel Navasa; Jaime Bosch; Conxita Bru; Pilar Pizcuet 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 879 KB

This study investigated whether oral doses of isosorbide-5-mononitrate, a preferential venous dilator that decreases portal pressure, could enhance the effects of propranolol on portal hypertension. Taking part in the study were 28 patients with cirrhosis and portal hypertension. Twenty patients (gr

Relationship between portal blood flow m
✍ Massimo Bolognesi; David Sacerdoti; Carlo Merkel; Angelo Gatta 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 642 KB

The validity of portal blood flow measurement in image-directed Doppler ultrasound (PBF-IDU) is still under debate. In this study PBF-IDU has been compared with hepatic blood flow measured by the indocyanine green constant infusion technique (HBF-ICG), which is the reference invasive method with wh

Effects of metoclopramide and domperidon
✍ Ricardo Mastai; Luis Grande; Jaime Bosch; Jordi Bruix; Joaquim Rigau; David Krav 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 507 KB

The effects of pharmacological manipulation of the lower esophageal sphincter pressure on the esophageal circulation in patients with cirrhosis and portal hypertension were investigated in 33 patients by measuring the azygos venous blood flow, which is an index of blood flow through esophageal varic